If you find this podcast useful please give it a rating and review on iTunes by clicking here
On today's Vox Markets Podcast: Shield Therapeutics U.S. Update, BPC becomes Challenger Energy and Paul Hill on Stocks to Watch
Tim Watts, CEO of Shield Therapeutics #STX provides a U.S. update and confirms they remain on track to launch Accrufer® in the US by the end of June 2021.
Shield is a commercial stage, pharmaceutical company with a focus on addressing iron deficiency with its lead product Feraccru® /Accrufer® (ferric maltol), a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anaemia.
Eytan Uliel, Chief Executive of Challenger Energy #CEG explains why they’ve changed their name from Bahamas Petroleum #BPC and give an updates on operational progress.
Challenger Energy is a Caribbean and Atlantic margin focused oil and gas company, with a range of exploration, appraisal, development and production assets and licences, located onshore in Trinidad and Tobago, and Suriname, and offshore in the waters of The Bahamas and Uruguay. In Trinidad and Tobago, Challenger Energy has five (5) producing fields, two (2) appraisal / development projects and a prospective exploration portfolio in the South West Peninsula. In Suriname, Challenger Energy has on onshore appraisal / development project. Challenger Energy's exploration licence in each of Uruguay and The Bahamas are highly prospective, and offer high-impact value exposure within the overall portfolio value. (Interview starts 9 minutes 41 seconds)
Paul Hill, full time investor and equity analyst gives his view on the market and stocks to watch: We also talk about what does the Indian variant mean for investors? And mention the following companies:
How many times each day should people look at shareprices?
How to stop yourself from buying everything?
(Interview starts 21 minutes 25 seconds)